[HTML][HTML] Effectiveness of DTaP Against Pertussis in≤ 2-Year-Old Children—Linyi Prefecture, Shandong Province, China, 2017–2019
P Zhu, D Wu, Y Wang, X Liu, LE Rodewald, Y Li… - China CDC …, 2023 - ncbi.nlm.nih.gov
Vaccine effectiveness (VE) is positively correlated with the number of administered co-
purified diphtheria, tetanus, and acellular pertussis vaccine (DTaP) doses. A matched case …
purified diphtheria, tetanus, and acellular pertussis vaccine (DTaP) doses. A matched case …
Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in …
ME Pichichero, AB Francis, SM Marsocci… - American Journal of …, 1993 - jamanetwork.com
• Objective—To compare the reactogenicity and immunogenicity of a diphtheria and tetanus
toxoids and two-component acellular pertussis (ADTP) vaccine with a US-licensed whole …
toxoids and two-component acellular pertussis (ADTP) vaccine with a US-licensed whole …
Comparison of antibody titers in eleven-to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines …
K Okada, K Ueda, K Morokuma… - The Pediatric …, 1998 - journals.lww.com
Materials and methods. Hisayama, where the current study was performed, is a semirural
town located near Fukuoka in southern Japan. Before the Vaccination Law in 1994, mass …
town located near Fukuoka in southern Japan. Before the Vaccination Law in 1994, mass …
Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity …
A Podda, G Bona, G Canciani, AMC Pistilli… - The Journal of …, 1995 - Elsevier
Objective: To evaluate the safety and the immunogenicity of a booster dose of recombinant
acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP, Biocine …
acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP, Biocine …
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
HJ Kwon, SB Han, BR Kim, KR Kang, DH Huh… - BMC infectious …, 2017 - Springer
Background Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during
adolescence was introduced in response to the resurgence of pertussis in various countries …
adolescence was introduced in response to the resurgence of pertussis in various countries …
Antibody response and reactions to completion of a four-dose series with a two-or three-component acellular pertussis vaccine compared to whole cell pertussis …
ME Pichichero, JL Green, AB Francis… - … journal of infectious …, 1996 - Taylor & Francis
We compared the reactions and immunogenicity of DT acellular pertussis (DTaP) vaccines
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …
Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccine in 2-and 3-month-old children in Japan
H Kamiya, R Nii, T Matsuda, N Yasuda… - American Journal of …, 1992 - jamanetwork.com
• Objective.—To compare the reactogenicity and immune response to the Takeda acellular
pertussis-component diphtheria-tetanus-pertussis (APDT) vaccine in children when …
pertussis-component diphtheria-tetanus-pertussis (APDT) vaccine in children when …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
A Tomovici, L Barreto, P Zickler, W Meekison, F Noya… - Vaccine, 2012 - Elsevier
Persistence of antibodies after a single dose of Tdap vaccine (tetanus, diphtheria, and 5-
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …
Overview of currently available Japanese acellular pertussis vaccines and future problems.
H Kamiya, R Nii - The Tokai Journal of Experimental and Clinical …, 1988 - europepmc.org
Acellular pertussis diphtheria, tetanus vaccine (APDT) was licensed in 1981 in Japan. This
vaccine contains pertussis toxin (PT), filamentous hemagglutinin (FHA) and agglutinogen …
vaccine contains pertussis toxin (PT), filamentous hemagglutinin (FHA) and agglutinogen …
Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …
SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …
vaccine is recommended in many countries for boosting immunity in adolescents and adults …